| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Apr―13 |
Predictors of post-COVID syndrome: opposing effects of arterial stiffness and targeted therapy in acute COVID-19 |
V. I. Podzolkov, Ilya I. Shvedov, Nino A. Dzhaiani, Anna E. Bragina |
| 2 |
[GO] |
2025―Jul―03 |
Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 - evidence of COVID-19 impact? |
S. A. Maksimov, S. A. Shalnova, Yu. A. Balanova, A. E. Imaeva, V. A. Kutsenko, M. B. Kotova, et al. (+51) G. A. Muromtseva, S. E. Evstifeeva, A. V. Kapustina, N. S. Karamnova, O. B. Shvabskaya, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, O. A. Bashkina, S. V. Glukhovskaya, I. A. Levina, E. A. Shirshova, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovieva, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, E. V. Mikhailov, Yu. O. Tarabrina, M. G. Ataev, M. O. Radzhabov, Z. M. Gasanova, M. A. Umetov, I. A. Hakuasheva, L. V. Elgarova, E. I. Yamashkina, L. A. Balykova, A. A. Usanova, A. M. Nikitina, N. V. Savvina, Yu. E. Spiridonova, E. A. Naumova, V. S. Yudin, A. A. Keskinov, S. M. Yudin, A. V. Kontsevaya, O. M. Drapkina |
| 3 |
[GO] |
2025―Apr―03 |
Successful treatment of acute inflammatory cardiomyopathy in a young patient with COVID-19: a clinical case |
O. V. Soldatova, I. Ya. Goryanskaya |
| 4 |
[GO] |
2025―Jan―21 |
Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) |
N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, et al. (+12) N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina |
| 5 |
[GO] |
2024―Dez―04 |
Association between renin-angiotensin system gene polymorphism and cardio-ankle vascular index in patients with COVID-19 |
V. I. Podzolkov, A. E. Bragina, E. S. Ogibenina, I. I. Shvedov, A. R. Komelkova |
| 6 |
[GO] |
2023―Mai―17 |
sVCAM-1 as a Marker of Endothelial Dysfunction associated with Severe Course of a Novel Coronavirus Infection (COVID-19) |
V. I. Podzolkov, A. E. Pokrovskaya, D. D. Vanina, I. I. Shvedov |
| 7 |
[GO] |
2023―Mrz―09 |
Arterial Hypertension and Severe COVID-19 in Hospitalized Patients: Data from a Cohort Study |
V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasilyeva, E. S. Ogibenina, E. E. Bykova, et al. (+3) I. I. Shvedov, A. A. Ivannikov, N. A. Druzhinina |
| 8 |
[GO] |
2023―Mrz―09 |
Acute Coronary Syndrome during the Pandemic New Coronavirus Infection |
O. M. Drapkina, A. Ya. Kravchenko, A. V. Budnevskiy, A. V. Kontsevaya, E. S. Ovsyannikov, E. S. Drobysheva |
| 9 |
[GO] |
2022―Nov―07 |
Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 |
A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, et al. (+13) V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina |
| 10 |
[GO] |
2022―Sep―09 |
Impact of the COVID-19 Pandemic on Myocardial Revascularization in Patients with Acute Coronary Syndrome in the Russian Federation |
B. G. Alekyan, S. A. Boytsov, V. I. Ganyukov, E. M. Manoshkina |
| 11 |
[GO] |
2022―Sep―09 |
Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels |
O. Ya. Porembskaya, V. N. Kravchuk, M. I. Galchenko, R. V. Deev, M. Sh. Chesnokov, A. V. Avanesyan, et al. (+7) K. V. Lobastov, S. N. Tsaplin, L. A. Laberko, V. S. Ermakov, O. V. Pashovkina, I. V. Schastlivtsev, S. A. Sayganov |
| 12 |
[GO] |
2022―Jul―07 |
Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER |
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk |
| 13 |
[GO] |
2022―Mai―06 |
Sequelae of COVID-19 at long-term follow-up after hospitalization |
N. V. Pogosova, F. N. Paleev, A. K. Ausheva, D. T. Kuchiev, S. A. Gaman, T. N. Veselova, et al. (+5) M. B. Belkind, O. Yu. Sokolova, R. A. Zhetisheva, S. K. Ternovoy, S. A. Boytsov |
| 14 |
[GO] |
2022―Mai―06 |
Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction |
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva |
| 15 |
[GO] |
2022―Jan―13 |
Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) |
S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, et al. (+12) V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina |
| 16 |
[GO] |
2022―Jan―13 |
Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 |
I. S. Yavelov |
| 17 |
[GO] |
2022―Jan―13 |
Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 1: Predictors of the Development of an Unfavorable Prognosis |
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva |
| 18 |
[GO] |
2021―Mai―08 |
The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 |
V. I. Podzolkov, A. I. Tarzimanova |
| 19 |
[GO] |
2020―Okt―17 |
COVID-19 Pneumonia in Patients with Chronic Myocarditis (HBV-Associated with InfarctLike Debute): Specifics of the Diseases Course, the Role of the Basic Therapy (Part II) |
O. V. Blagova, N. V. Varionchik, M. M. Beraia, V. A. Zaidenov, E. A. Kogan, N. D. Sarkisova, A. V. Nedostup |
| 20 |
[GO] |
2020―Sep―04 |
COVID-19 Pneumonia in Patients with Chronic Myocarditis (Recurrent Infectious Immune): Specifics of the Diseases Course, the Role of Basic Therapy (Part 1) |
O. V. Blagova, N. V. Varionchik, M. M. Beraia, V. A. Zaidenov, E. A. Kogan, N. D. Sarkisova, A. V. Nedostup |
| 21 |
[GO] |
2020―Jul―06 |
Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs |
O. V. Gaisenok |
| 22 |
[GO] |
2020―Apr―22 |
Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine |
S. Yu. Martsevich |
|
